Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Onyx Weight Loss vs Potere Health MD

Onyx Weight Loss
Graded #359

Lower grade

vs+13.700000000000003
Potere Health MD
Graded #77

Higher grade

The verdict

Potere Health MD takes it — 72.5/100 to 58.8/100.

Potere Health MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Potere Health MD is a Utah-based, physician-led weight loss clinic offering semaglutide and tirzepatide in both FDA-approved and compounded forms via telehealth and in-person visits.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePotere Health MD +42
43
85
Dose & formulationEven
64
64
Clinical oversightPotere Health MD +12
75
87
Labs & monitoringOnyx Weight Loss +9
63
54
FulfillmentPotere Health MD +14
53
67
Contract termsPotere Health MD +6
55
61
Onyx Weight Loss · left barPotere Health MD · right bar

The numbers

MetricOnyx Weight LossPotere Health MD
WeighScore58.8/10072.5/100
GradeCC
Scorecard rank#359#77
Semaglutide$228/mo (starting dose, compounded)$80/mo (starting dose, compounded)
Tirzepatide$280/mo (starting dose, compounded)$135/mo (starting dose, compounded)
Coverage8 states1 state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Onyx Weight Loss

Graded #359 · C

Strengths

  • Competitive entry pricing: semaglutide from $228/mo and tirzepatide from $280/mo with medication + supplies included
  • Nurse-practitioner-led care: founder Tasha Vangile FNP-C (20+ years) and Stephanie Robison APRN-CNP (27 years experience)
  • Low-cost $99/mo GLP-1 microdosing option for patients who prefer a gradual titration start
  • Strive Pharmacy partnership implies compounded 503A-quality supply chain from a known pharmacy
  • Multi-modal clinic: GLP-1 + peptides + HRT + nutrition coaching available under one provider team

Where it loses points

  • Only 8 states (NC, CO, ME, VT, VA, IA, NH, PA) — excludes the majority of the US
  • No LegitScript certification; credentialing evidence limited to local 2025 Best of Iredell award
  • Specific drug names (semaglutide/tirzepatide) never stated on website; compounded status inferred, not disclosed
  • Labs not included or mentioned; no baseline bloodwork protocol published
  • Pricing shown as 'Starting at' with no dose-escalation tier pricing disclosed publicly
Potere Health MD

Graded #77 · C

Strengths

  • Low starting pricing (about $80-$135/month) with no subscription lock-in
  • Physician-led by a named MD, not automated messaging
  • Third-party COA and LegitScript-certified pharmacy
  • Both telehealth and in-person Utah visits with fast scheduling

Where it loses points

  • Available in Utah only — a St George clinic offering telehealth within the state, not a national service
  • The per-vial price is fixed, so the monthly cost rises steeply with the dose: the provider's own table runs about $20/mo at 0.25 mg, $80/mo at 1.0 mg and about $199/mo at 2.5 mg
  • Medication is bought per vial up front rather than on a subscription, so there is no monthly rate to compare directly against a subscription programme
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard